ArticleCell death & disease2022

Anti-ANGPTL3-FLD monoclonal antibody treatment ameliorates podocyte lesions through attenuating mitochondrial damage.

Qianying Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.